WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'0301 Infant (under 12 months) mortality rate: 272
GDP / capita (US$): 7'2001 Child (under 5 years) mortality rate: 312

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 33'493  33'008  32'521  32'059  31'642  28'710  24'675  19'799 
Births 753  750  739  720  696  631  740  770 
Surviving infants 734  731  719  700  676  605  697  698 
Pop. less than 5 years 3'584  3'422  3'234  3'077  2'984  3'118  3'457  3'229 
Pop. less than 15 years 9'354  9'194  9'035  8'927  8'899  9'776  9'987  8'716 
Female 15-49 years 9'230  9'206  9'176  9'125  9'048  7'804  5'941  4'534 

Number of reported case

(Click for retrospective incidence data for Morocco)
Diphtheria 43 
Japanese encephalitis
Measles 10  92  668  982  633  7'368  1'577  86'919 
Mumps
Pertussis 72  172  35  15  22  83  14'873 
Polio* 52 
Rubella 59 
Rubella (CRS)
Tetanus (neonatal) 28 
Tetanus (total)** 23  69  16  20  73  81 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Morocco)
Vaccine year result method % card seen                                                
BCG          99*  99*  99*  99*  99*  97  96 
DTP1          99*  99*  99*  99*  99*  98 
DTP3          99  99  99  99  99*  95  81 
HepB_BD          99*  99*  99*  99*  99  10 
HepB3          99  99  99*  98  98  43 
Hib3          99  99  99  98  99* 
JapEnc         
MCV          99  99  99  99*  98  93  79 
MCV2          95  10 
PCV1          99  99  86  91  16 
PCV3          80  80  72  23 
Pol3          99  99  99  98  99*  95  81 
Rota1          95  95  91  87  17 
Rota_last          90  90  88  80 
Rubella1         
TT2plus 1994  54  DHS   51  90  64 
PAB         
VAD1          98  98  80  80  76  40 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Morocco)
BCG 99  99  99  99  97  96 
DTP1 99  99  99  99  98  93 
DTP3 99  99  99  99  95  81 
HepB3 99  99  98  98  43 
HepB_BD 14  20 
Hib3 99  99  99  99 
MCV 99  99  99  98  93  79 
MCV2
PAB 89  89  89  89  86  66 
PCV3 80  72  23 
Pol3 99  99  98  99  95  81 
Rota_last 90  88  80 

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 91
From 80 to 89% 9
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 1 month; Yes
DTwP 18 months; 5 years; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB birth; Yes
IPV 4 months; Yes From June 2015
MR 9 months; Yes
Measles 18 months; Yes
OPV 1, 2, 3, 4, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 3,4 months; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2008-2012  2008-2012  2008-2012  2010-2012  2009-20011 
Nº of districts with microplans that include activities to raise immunization coverage number 81  81  81  81  68  68  68 

System performance

Total Nº districts in country number 81  81  81  81  68  68  68 
Nº districts with DTP3 coverage >=80% number 81  81  80  79  68  68  67 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  99  98  100  100  99 
Nº districts with measles (MCV1) coverage >=95% number 56  51  65  47  45  39  32 
% of districts with MCV1 coverage >=95% From 0 to 100% 69  63  80  58  66  57  47 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%         101  100  80 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.